Tina Matthews-Hayes
Psychiatric/Mental Health · Portland, ORNPI 1063726578
Payments from drug & device makers
Across 1,263 payments — averaging $622.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$630K
- Johnson & Johnson$71K
- Neurocrine Biosciences, Inc.$63K
- Biogen$13K
- Teva Pharmaceuticals USA, Inc.$6K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $3K from 12 others
Across 2 payments — averaging $346.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$692
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 890 | $629,562 |
| Johnson & Johnson | 98 | $71,280 |
| Neurocrine Biosciences, Inc. | 94 | $62,583 |
| Biogen | 5 | $12,688 |
| Teva Pharmaceuticals USA, Inc. | 65 | $5,719 |
| E.r. Squibb & Sons, L.L.C. | 11 | $2,108 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $1,000 |
| Alkermes, Inc. | 12 | $385 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $365 |
| Otsuka America Pharmaceutical, Inc. | 23 | $304 |
| Supernus Pharmaceuticals, Inc. | 25 | $248 |
| Sunovion Pharmaceuticals Inc. | 18 | $227 |
| Corium, LLC | 5 | $102 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Neos Therapeutics, LP | 1 | $11 |
How this compares
$786,688 in reported general payments places this provider in the 95th percentile of 540 psychiatric/mental health providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatric/mental health in Portland
- Johnni CanslerPortland$529K
- Jill CarterPortland$416K
- Michelle VoegelsPortland$29K
- Corinne RekartPortland$4K
- Kalesha JonesPortland$2K
- Tamara JohnsonPortland$2K
- Orawan LaochumnanvanitPortland$2K
- Samantha LauPortland$2K
- Rebecca BermanPortland$2K
- Tara CandelaPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.